<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29843" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Systolic Hypertension</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tan</surname>
            <given-names>Jian Liang</given-names>
          </name>
          <aff>Crozer-Chester MC/Drexel Un</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thakur </surname>
            <given-names>Kshitij</given-names>
          </name>
          <aff>Drexel University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jian Liang Tan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kshitij Thakur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29843.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Isolated systolic hypertension is the predominant form of hypertension in the older adult population. Traditionally it has been defined as systolic blood pressure (SBP) above 140 mm Hg with diastolic blood pressure of less than 90 mm Hg. It is estimated that 15 percent of people 60 years old and above have isolated systolic hypertension. Per the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines, however, an SBP of 130 mm Hg is now considered hypertensive at all ages. The new definition of hypertension will lead to an increased number of elderly being diagnosed with high blood pressure. Isolated systolic hypertension remains an important public health concern as chronically untreated high SBP can carry significant mortality and morbidity. This activity reviews the evaluation and management of isolated systolic hypertension and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the factors that contribute to systolic hypertension.</p></list-item><list-item><p>Review the diagnosis of systolic hypertension.</p></list-item><list-item><p>Explain management strategies for systolic hypertension.</p></list-item><list-item><p>Summarize the importance of collaboration and coordination among the interprofessional team in optimizing the care of patients with systolic hypertension.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29843&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29843">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29843.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Isolated systolic hypertension is the predominant form of hypertension in the older adut population.<xref ref-type="bibr" rid="article-29843.r1">[1]</xref>&#x000a0;Traditionally defined as systolic blood pressure (SBP) above 140 mm Hg&#x000a0;with diastolic blood pressure (DBP) of less than 90 mm Hg, it is estimated that 15% of people aged 60 years and above have isolated systolic hypertension. Per the 2017 American College of Cardiology/American Heart Association Blood Pressure guidelines, however, an SBP of 130 mm Hg is now considered hypertensive at all ages.<xref ref-type="bibr" rid="article-29843.r2">[2]</xref>&#x000a0;The new definition of hypertension will lead to an increased number of elderly being diagnosed with high blood pressure. Isolated systolic hypertension remains an important public health concern as chronically untreated high SBP carries significant mortality and morbidity.</p>
      </sec>
      <sec id="article-29843.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most patients with hypertension have primary hypertension, which is also known as essential hypertension. Rarely, isolated systolic hypertension is attributed to other causes of secondary hypertension such as hypothyroidism/hyperthyroidism, chronic kidney disease, peripheral vascular disease, diabetes mellitus, aortic insufficiency, arteriovenous fistula, anemia, Paget disease, and atherosclerotic renal artery stenosis.<xref ref-type="bibr" rid="article-29843.r3">[3]</xref></p>
      </sec>
      <sec id="article-29843.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Isolated systolic hypertension is common in the elderly population. Based on data from&#x000a0;the National Health and Nutrition Examination Survey 1999-2010, approximately 30% of persons aged 60 years and older have untreated isolated systolic hypertension, as compared with 6% in adults aged 40 to 50 years and 1.8% in young adults aged 18 to 39 years.<xref ref-type="bibr" rid="article-29843.r3">[3]</xref><xref ref-type="bibr" rid="article-29843.r4">[4]</xref><xref ref-type="bibr" rid="article-29843.r5">[5]</xref>&#x000a0;As per the Framingham Heart Study, a person aged 65 years with normal blood pressure has a 90% lifetime risk of developing hypertension. Among the elderly group, women and non-Hispanic Blacks have a higher prevalence of hypertensive disorders.</p>
      </sec>
      <sec id="article-29843.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Isolated systolic hypertension, in most cases, develops as a result of the reduced elasticity of the arterial system. This is commonly seen among the older adult population as there is an increased deposition&#x000a0;of calcium and collagen to the arterial wall.<xref ref-type="bibr" rid="article-29843.r6">[6]</xref>&#x000a0;Hence, this&#x000a0;may result in reduced compliance of the arterial vessels, decreased lumen-to-wall ratio, and increased thickening and fibrotic remodeling of the vascular intima and media. As a result,&#x000a0;these stiffened&#x000a0;conduit arteries lead to&#x000a0;an increase in pulse pressure and pulse wave velocity, causing an elevation in&#x000a0;SBP and a further decline in&#x000a0;DBP. Similarly, chronic&#x000a0;diseases such as the above causes of secondary hypertension may contribute to the same pathological process by accelerating the deposition of calcium and collagen to the arterial system and the fibrotic remodeling of the vascular walls.<xref ref-type="bibr" rid="article-29843.r6">[6]</xref><xref ref-type="bibr" rid="article-29843.r7">[7]</xref></p>
      </sec>
      <sec id="article-29843.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Isolated systolic hypertension, like any other hypertensive disorder, often&#x000a0;results in end-organ damage when untreated. Hence, early diagnosis, addressing modifiable risk factors, and initiating appropriate treatment are prudent to decrease morbidity and mortality. The important aspects of the history of&#x000a0;the hypertensive patient include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intake of precipitating agents&#x000a0;such as nonsteroidal anti-inflammatory drugs, steroids, sympathomimetics, cocaine, steroids, estrogen</p>
          </list-item>
          <list-item>
            <p>Risk factors such as smoking, diabetes, dyslipidemia, obesity, sedentary lifestyle, unhealthy diet</p>
          </list-item>
          <list-item>
            <p>Diet, including high salt, processed food, high fat, and alcohol intake</p>
          </list-item>
          <list-item>
            <p>Family&#x000a0;history of hypertension, renal disease, diabetes, or cardiovascular disease</p>
          </list-item>
          <list-item>
            <p>Symptoms of secondary causes such as spells of tremor, sweating or tachycardia, muscle weakness, thinning of the skin, depression, hematuria, loud snoring, and daytime somnolence</p>
          </list-item>
          <list-item>
            <p>Symptoms of end-organ damage such as headaches, loss of visual acuity, dyspnea, chest pain, and claudication&#x000a0;<xref ref-type="bibr" rid="article-29843.r2">[2]</xref><xref ref-type="bibr" rid="article-29843.r8">[8]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>
<bold>Accurate blood pressure measurement</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Reassess normal blood pressure yearly.</p>
          </list-item>
          <list-item>
            <p>Take blood pressure after the patient rests for five minutes.</p>
          </list-item>
          <list-item>
            <p>The patient should sit in a chair with both feet flat on the ground and the back straight.</p>
          </list-item>
          <list-item>
            <p>The patient's arm should be placed on a flat surface at the level of the chest or heart.</p>
          </list-item>
          <list-item>
            <p>Choosing the right cuff size is important.</p>
          </list-item>
          <list-item>
            <p>SBP is the first Korotkoff sound.</p>
          </list-item>
          <list-item>
            <p>DBP is the fifth Korotkoff sound.</p>
          </list-item>
          <list-item>
            <p>Obtain an average of 2 to 3 blood pressure measurements on two or three separate&#x000a0;occasions to confirm a hypertension diagnosis.</p>
          </list-item>
        </list>
        <p>
<bold>General appearance</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Body mass index calculation</p>
          </list-item>
          <list-item>
            <p>Signs of Cushing syndrome such as buffalo&#x000a0;hump, moon face, thinning of the skin, and red or purple striae</p>
          </list-item>
          <list-item>
            <p>Restlessness</p>
          </list-item>
          <list-item>
            <p>Sweating</p>
          </list-item>
          <list-item>
            <p>Flushing</p>
          </list-item>
          <list-item>
            <p>Neurofibromatosis</p>
          </list-item>
        </list>
        <p>
<bold>Neck</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Thyroid enlargement</p>
          </list-item>
          <list-item>
            <p>Carotid bruits</p>
          </list-item>
        </list>
        <p>
<bold>Fundoscopy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Papilledema</p>
          </list-item>
          <list-item>
            <p>Cotton wool spots</p>
          </list-item>
          <list-item>
            <p>Arteriolar narrowing</p>
          </list-item>
          <list-item>
            <p>Arteriovenous nicking</p>
          </list-item>
          <list-item>
            <p>Hemorrhage</p>
          </list-item>
        </list>
        <p>
<bold>Heart</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Gallop rhythm, S4</p>
          </list-item>
          <list-item>
            <p>Heave</p>
          </list-item>
          <list-item>
            <p>Jugular venous distension</p>
          </list-item>
        </list>
        <p>
<bold>Lungs</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rales</p>
          </list-item>
          <list-item>
            <p>Rhonchi</p>
          </list-item>
        </list>
        <p>
<bold>Abdomen</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Enlarged kidneys</p>
          </list-item>
          <list-item>
            <p>Aorta or renal bruits</p>
          </list-item>
        </list>
        <p>
<bold>Neurologic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Visual changes</p>
          </list-item>
          <list-item>
            <p>Confusion</p>
          </list-item>
          <list-item>
            <p>focal weakness</p>
          </list-item>
        </list>
        <p>
<bold>Extremities</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Peripheral pulses</p>
          </list-item>
          <list-item>
            <p>Pedal edema</p>
          </list-item>
          <list-item>
            <p>Cold peripheral limbs</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29843.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Further Evaluation</bold>
</p>
        <p>When systolic hypertension is suspected based on reliable measurements, perform a further&#x000a0;evaluation to determine the following:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>The presence or absence of cardiovascular risk factors</p>
          </list-item>
          <list-item>
            <p>The extent of the end-organ damage</p>
          </list-item>
          <list-item>
            <p>Identifiable causes of hypertension</p>
          </list-item>
          <list-item>
            <p>Concomitant&#x000a0;clinical conditions affecting&#x000a0;prognosis and treatment&#x000a0;<xref ref-type="bibr" rid="article-29843.r2">[2]</xref><xref ref-type="bibr" rid="article-29843.r8">[8]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Routine Laboratory and Clinical Investigation</bold>
</p>
        <p>These tests should be performed to evaluate cardiovascular risk and concomitant diseases.</p>
        <list list-type="bullet">
          <list-item>
            <p>12-lead electrocardiographic (left ventricular hypertrophy features, atrial dilation, and arrhythmias)</p>
          </list-item>
          <list-item>
            <p>Lipid panels (calculate 10-year atherosclerotic cardiovascular disease risk)</p>
          </list-item>
          <list-item>
            <p>Serum creatinine (with an estimation of glomerular filtration rate)</p>
          </list-item>
          <list-item>
            <p>Serum electrolytes (sodium and potassium)</p>
          </list-item>
          <list-item>
            <p>Thyroid-stimulating hormone</p>
          </list-item>
          <list-item>
            <p>Urine analysis (proteinuria)</p>
          </list-item>
          <list-item>
            <p>Urine microalbuminuria</p>
          </list-item>
        </list>
        <p>
<bold>Additional Tests<italic toggle="yes"/></bold>
</p>
        <p>Perform the following tests based on the relevant history, physical examination, and routine laboratory findings.</p>
        <list list-type="bullet">
          <list-item>
            <p>Hemoglobin A1c</p>
          </list-item>
          <list-item>
            <p>Serum uric acid</p>
          </list-item>
          <list-item>
            <p>Ankle-brachial index</p>
          </list-item>
          <list-item>
            <p>Renal ultrasound and renal Doppler ultrasonography</p>
          </list-item>
          <list-item>
            <p>Quantitative proteinuria (urine protein to creatinine&#x000a0;ratio, 24-hour urine protein)</p>
          </list-item>
          <list-item>
            <p>Echocardiogram (patient with heart failure)</p>
          </list-item>
          <list-item>
            <p>Specific tests to search for secondary causes of hypertension (plasma-free metanephrines, 24-hour urinary cortisol, aldosterone-renin ratio)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29843.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>New classifications&#x000a0;of blood pressure according to the 2017 American College of Cardiology/American Heart Association guidelines:<xref ref-type="bibr" rid="article-29843.r2">[2]</xref></p>
        <p>
<bold>Normal</bold>
<bold>&#x000a0;Blood Pressure</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>SBP less than 120 mm Hg and DBP less than 80 mm Hg</p>
          </list-item>
          <list-item>
            <p>Promote lifestyle modification</p>
          </list-item>
        </list>
        <p>
<bold>Elevated Blood Pressure</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>SBP 120 to 129 mm Hg and DBP less than 80 mm Hg</p>
          </list-item>
          <list-item>
            <p>Initiate nonpharmacologic therapy and reassess in 3 to 6 months</p>
          </list-item>
        </list>
        <p>
<bold>Hypertension Stage 1</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>SBP 130 to 139 mm Hg or DBP 80 to 89 mm Hg</p>
          </list-item>
          <list-item>
            <p>Patients without ASCVD or 10-year atherosclerotic cardiovascular disease (ASCVD) risk less than 10%: Initiate nonpharmacologic therapy for all patients and reassess in 3 to 6 months</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Patient with ASCVD or 10-year ASCVD risk equal to or greater than 10%:</italic>&#x000a0;initiate nonpharmacologic therapy and single oral antihypertensive agent and reassess patient in 1 month</p>
          </list-item>
        </list>
        <p>
<bold>Hypertension Stage 2</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>SBP more than 139 mm Hg or DBP less than 89 mm Hg</p>
          </list-item>
          <list-item>
            <p>Initiate nonpharmacologic therapy and single oral antihypertensive agent and reassess patient in 1 month</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">*If the blood pressure goal is not met, assess and optimize adherence to therapy or consider intensification of therapy.</italic>
</p>
        <p>
<italic toggle="yes">*If the blood pressure goal is met, reassess in 3 to 6 months.</italic>
</p>
        <p>Several clinical trials such as hypertension in the very elderly (HYVET) and systolic hypertension in the elderly program (SHEP) have shown that active treatment of isolated systolic hypertension in older adults resulted in significant reductions in the all-cause mortality (13%), cardiovascular mortality (18%), and stroke (30%) and coronary (23%) events as compared with placebo.</p>
        <p>Treatment of hypertension can be divided into nonpharmacologic and pharmacologic therapy.<xref ref-type="bibr" rid="article-29843.r2">[2]</xref><xref ref-type="bibr" rid="article-29843.r8">[8]</xref></p>
        <p>
<bold>Nonpharmacologic Therapy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Recommended for all&#x000a0;patients, regardless of the&#x000a0;reading of the blood pressure.</p>
          </list-item>
          <list-item>
            <p>Restrict dietary salt (aim for 1.5 g or less per day). Randomized controlled trials have shown that moderate sodium reduction can result in an average blood pressure reduction of 4.8/2.5 mmHg).</p>
          </list-item>
          <list-item>
            <p>Weight loss (every 1 pound or 0.45 kg of weight loss will result in a reduction of 1 mmHg blood pressure).</p>
          </list-item>
          <list-item>
            <p>Start dietary approaches to stop hypertension (DASH) diet (rich in fruits, vegetables, whole grains, fish, and low-fat dairy products). A clinical&#x000a0;trial has shown that the DASH diet helps to reduce blood pressure by an average of 6/4 mm Hg.</p>
          </list-item>
          <list-item>
            <p>Increase physical activity. Aerobic and resistance training can reduce blood pressure by an average of 4/3 to 6/3 mm Hg, irrespective of body weight.</p>
          </list-item>
          <list-item>
            <p>Limit alcohol intake to no&#x000a0;more than&#x000a0;one alcoholic drink per day for women and two for men.</p>
          </list-item>
          <list-item>
            <p>Take a potassium supplement (unless contraindicated in chronic kidney disease patients).</p>
          </list-item>
          <list-item>
            <p>Quit smoking.</p>
          </list-item>
          <list-item>
            <p>Use stress management.</p>
          </list-item>
        </list>
        <p>
<bold>Pharmacologic Therapy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In general, start off with a single-agent oral antihypertensive drug therapy, especially in the elderly because of the risk of orthostatic hypotension.</p>
          </list-item>
          <list-item>
            <p>An exception to the above is when the initial SBP is above 160 or blood pressure is 20/10 mm Hg above the goal of blood pressure, which often needs the initiation of two oral antihypertensive agents.</p>
          </list-item>
          <list-item>
            <p>The four major classes of oral antihypertensive agents include thiazide-like diuretics (chlorthalidone and indapamide), dihydropyridine calcium channel blockers (CCBs: amlodipine, nifedipine, nitrendipine), angiotensin-converting enzyme inhibitors (ACEi: lisinopril, ramipril), and angiotensin receptor blockers (ARBs: losartan, valsartan).</p>
          </list-item>
          <list-item>
            <p>Randomized controlled trials have shown that thiazide-like diuretics and CCBs are the preferred first-line agents&#x000a0;in reducing the risk of stroke and other morbidities&#x000a0;in patients with isolated systolic hypertension.</p>
          </list-item>
          <list-item>
            <p>The&#x000a0;dose of the single oral antihypertensive agent should be titrated to the maximum before initiating a second oral antihypertensive agent.</p>
          </list-item>
          <list-item>
            <p>In patients who require two oral antihypertensive agents, a combination of thiazide-like diuretic and CCB is the preferred strategy.</p>
          </list-item>
          <list-item>
            <p>ACEi or ARB&#x000a0;is often used in patients with compelling indications such as heart failure reduced ejection, post-myocardial infarction, diabetes, or chronic kidney disease.</p>
          </list-item>
          <list-item>
            <p>A combination of either ACEi or&#x000a0;ARB with&#x000a0;CCB or a thiazide-like diuretic&#x000a0;can&#x000a0;be&#x000a0;considered.</p>
          </list-item>
          <list-item>
            <p>It is important to note that ACEi should&#x000a0;never be used concomitantly with ARB under any circumstances.</p>
          </list-item>
          <list-item>
            <p>Patients with secondary causes of hypertension should have their respective diseases addressed concurrently.</p>
          </list-item>
          <list-item>
            <p>Studies have shown that the use of beta-blockers in the management of hypertension is inferior compared with ARB, ACEi, or CCB for cardiovascular and stroke risk reduction.</p>
          </list-item>
        </list>
        <p>B<bold>lood Pressure Goals</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>SHEP and HYVET trials have shown significant benefits of antihypertensive treatment in patients with the goal of SBP less than 150 mm Hg.<xref ref-type="bibr" rid="article-29843.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>The valsartan in elderly isolated systolic hypertension (VALISH) trial showed no significant difference in the primary outcome of sudden death, fatal or nonfatal myocardial infarction and stroke, heart failure death, or other cardiovascular death among patients with strict (less than 140 mm Hg)&#x000a0;and moderate (140 to 150 mm Hg) SBP control.<xref ref-type="bibr" rid="article-29843.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>However, the VALISH trial&#x000a0;was underpowered due to the low number of events.</p>
          </list-item>
          <list-item>
            <p>Hence,&#x000a0;the optimal SBP in patients with hypertensive disorders remained a controversial topic.</p>
          </list-item>
          <list-item>
            <p>The most recent systolic blood pressure intervention trial (SPRINT) has shown that an intensive SBP target of less than 120 mm Hg improved cardiovascular outcomes and overall survival compared to the standard SBP target of 135 to 139 mm Hg.<xref ref-type="bibr" rid="article-29843.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>However,&#x000a0;aggressive SBP lowering may be harmful in the elderly and incite more adverse effects such as hypotension, end-organ hypoperfusion (causing acute kidney injury, and intracranial hypoperfusion which may link to cognitive decline), and polypharmacy.</p>
          </list-item>
          <list-item>
            <p>It is suggested that a goal blood pressure of less than 130/80 mmHg is appropriate as long as the patient tolerates it.</p>
          </list-item>
          <list-item>
            <p>Otherwise, less than 140/90 mmHg is considered reasonable in patients who are in the elderly population and patients with labile blood pressure or polypharmacy.</p>
          </list-item>
          <list-item>
            <p>Management strategies should always be patient-centered, with the aim of optimizing blood pressure control and avoiding polypharmacy, especially in the elderly.</p>
          </list-item>
        </list>
        <p>
<bold>J-curve Phenomenon</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Various studies have shown a J-curve&#x000a0;association between blood pressure and with risk of myocardial infarction and death.</p>
          </list-item>
          <list-item>
            <p>Patients with isolated systolic hypertension who receive antihypertensive treatment may precipitously drop their DBP as well.</p>
          </list-item>
          <list-item>
            <p>As myocardial perfusion occurs mainly during diastole, an excessive drop in DBP&#x000a0;may increase the risk of cardiovascular disease and death.<xref ref-type="bibr" rid="article-29843.r12">[12]</xref><xref ref-type="bibr" rid="article-29843.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29843.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is important to identify white coat hypertension and masked hypertension&#x000a0;correctly as over- or under-treatment&#x000a0;of hypertension can have significant morbidity&#x000a0;and mortality.</p>
        <p>
<bold>Whitecoat Hypertension</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Consistently elevated office&#x000a0;blood pressure but normal out-of-office blood pressure</p>
          </list-item>
        </list>
        <p>
<bold>Masked Hypertension</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Consistently elevated out-of-office blood pressure but normal office blood pressure</p>
          </list-item>
        </list>
        <p>
<bold>Pseudo-hypertension</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Result of calcified blood vessels that cause incompressible peripheral arteries</p>
          </list-item>
          <list-item>
            <p>The blood pressure cuff is unable to measure the intraluminal blood pressure accurately</p>
          </list-item>
          <list-item>
            <p>This causes a false elevation of blood pressure reading</p>
          </list-item>
          <list-item>
            <p>The use of standing blood pressure measurement can help to differentiate pseudo-hypertension from true hypertension</p>
          </list-item>
          <list-item>
            <p>Patients&#x000a0;with&#x000a0;poorly controlled blood pressure should be evaluated for pseudo-hypertension before&#x000a0;being labeled as resistant hypertension&#x000a0;<xref ref-type="bibr" rid="article-29843.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29843.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Mild to moderate hypertension may be associated with a risk of atherosclerotic disease&#x000a0;if left untreated in 30% of people and organ damage in 50% of people within 8 to 10 years after onset. Patients with resistant hypertension also have a higher risk for poor outcomes, especially for those with certain comorbidities (eg, chronic kidney disease and ischemic heart disease). Patients with resistant hypertension who have lower blood pressure appear to have a reduced risk for some cardiovascular events (eg, incident stroke, coronary heart disease, or heart failure).</p>
      </sec>
      <sec id="article-29843.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Uncontrolled high systolic blood pressure can lead to the following complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Myocardial infarction</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Peripheral vascular disease</p>
          </list-item>
          <list-item>
            <p>Aneurysm</p>
          </list-item>
          <list-item>
            <p>Chronic kidney disease</p>
          </list-item>
          <list-item>
            <p>Retinopathy</p>
          </list-item>
          <list-item>
            <p>Erectile dysfunction</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29843.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Hypertension is a chronic disorder. For optimal control, lifestyle modifications and pharmacologic therapy are required. The following lifestyle modifications can help to control blood pressure:</p>
        <list list-type="bullet">
          <list-item>
            <p>Daily aerobic physical activity</p>
          </list-item>
          <list-item>
            <p>Diets low in salt, total fat, and cholesterol</p>
          </list-item>
          <list-item>
            <p>Adequate dietary intake of potassium, calcium, and magnesium</p>
          </list-item>
          <list-item>
            <p>Limited alcohol consumption</p>
          </list-item>
          <list-item>
            <p>Quit cigarette smoking</p>
          </list-item>
          <list-item>
            <p>Avoidance of the use of illicit drugs, such as cocaine</p>
          </list-item>
          <list-item>
            <p>Weight loss for obese patients</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29843.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Isolated systolic hypertension is common in the&#x000a0;elderly population.&#x000a0;SBP has a better prediction for the risk of cardiovascular&#x000a0;disease as compared to DBP. Hence, treatment of isolated systolic hypertension is beneficial to reduce all-cause mortality cardiovascular risk, and stroke. The optimal SBP remained unclear, but an SBP&#x000a0;goal of less than 140 mm Hg and keeping DBP at 70 mm Hg or higher are considered appropriate in most patient populations.</p>
      </sec>
      <sec id="article-29843.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Systolic hypertension is commonly encountered in clinical practice. Because it is a major risk factor for adverse cardiac events, the condition must be appropriately managed. The nurse practitioner, primary care provider, internist, cardiologist,&#x000a0;and emergency room provider must be aware of the latest American College of Cardiology guidelines on the management of hypertension. Because of the numerous drugs available to treat hypertension, a consult with a cardiologist is highly recommended if there is any doubt about the efficacy of the drug. There is ample evidence showing that when systolic hypertension is well treated, the patients have good outcomes with an interprofessional&#x000a0;approach to care.<xref ref-type="bibr" rid="article-29843.r15">[15]</xref><xref ref-type="bibr" rid="article-29843.r16">[16]</xref><xref ref-type="bibr" rid="article-29843.r17">[17]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-29843.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29843&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29843">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/systolic-hypertension/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29843">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29843/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29843">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29843.s16">
        <title>References</title>
        <ref id="article-29843.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bavishi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Messerli</surname>
                <given-names>FH</given-names>
              </name>
            </person-group>
            <article-title>Isolated Systolic Hypertension: An Update After SPRINT.</article-title>
            <source>Am J Med</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>129</volume>
            <issue>12</issue>
            <fpage>1251</fpage>
            <page-range>1251-1258</page-range>
            <pub-id pub-id-type="pmid">27639873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whelton</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Aronow</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Dennison Himmelfarb</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>DePalma</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gidding</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jamerson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>MacLaughlin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ovbiagele</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Taler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Oct</month>
            <day>23</day>
            <volume>138</volume>
            <issue>17</issue>
            <fpage>e484</fpage>
            <page-range>e484-e594</page-range>
            <pub-id pub-id-type="pmid">30354654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viera</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Neutze</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of secondary hypertension: an age-based approach.</article-title>
            <source>Am Fam Physician</source>
            <year>2010</year>
            <month>Dec</month>
            <day>15</day>
            <volume>82</volume>
            <issue>12</issue>
            <fpage>1471</fpage>
            <page-range>1471-8</page-range>
            <pub-id pub-id-type="pmid">21166367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egan</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hutchison</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Ferdinand</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Nov</month>
            <day>04</day>
            <volume>130</volume>
            <issue>19</issue>
            <fpage>1692</fpage>
            <page-range>1692-9</page-range>
            <pub-id pub-id-type="pmid">25332288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and trends of isolated systolic hypertension among untreated adults in the United States.</article-title>
            <source>J Am Soc Hypertens</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-205</page-range>
            <pub-id pub-id-type="pmid">25795550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>AlGhatrif</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lakatta</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>The conundrum of arterial stiffness, elevated blood pressure, and aging.</article-title>
            <source>Curr Hypertens Rep</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">25687599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chobanian</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Isolated systolic hypertension in the elderly.</article-title>
            <source>N Engl J Med</source>
            <year>2007</year>
            <month>Aug</month>
            <day>23</day>
            <volume>357</volume>
            <issue>8</issue>
            <fpage>789</fpage>
            <page-range>789-96</page-range>
            <pub-id pub-id-type="pmid">17715411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mancia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fagard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Narkiewicz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Redon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zanchetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christiaens</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cifkova</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dominiczak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Galderisi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grobbee</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Jaarsma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kirchhof</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kjeldsen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Manolis</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Ruilope</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Schmieder</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Sirnes</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sleight</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Viigimaa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Waeber</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zannad</surname>
                <given-names>F</given-names>
              </name>
              <collab>Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology</collab>
            </person-group>
            <article-title>2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.</article-title>
            <source>Blood Press</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-16</page-range>
            <pub-id pub-id-type="pmid">24359485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <article-title>Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.</article-title>
            <source>JAMA</source>
            <year>1991</year>
            <month>Jun</month>
            <day>26</day>
            <volume>265</volume>
            <issue>24</issue>
            <fpage>3255</fpage>
            <page-range>3255-64</page-range>
            <pub-id pub-id-type="pmid">2046107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beckett</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Staessen</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dumitrascu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stoyanovsky</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Antikainen</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Nikitin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Belhani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Forette</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rajkumar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thijs</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Banya</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bulpitt</surname>
                <given-names>CJ</given-names>
              </name>
              <collab>HYVET Study Group</collab>
            </person-group>
            <article-title>Treatment of hypertension in patients 80 years of age or older.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>May</month>
            <day>01</day>
            <volume>358</volume>
            <issue>18</issue>
            <fpage>1887</fpage>
            <page-range>1887-98</page-range>
            <pub-id pub-id-type="pmid">18378519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>SPRINT Research Group</collab>
              <name>
                <surname>Wright</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Whelton</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Sink</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rocco</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Reboussin</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oparil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Kimmel</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Goff</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ambrosius</surname>
                <given-names>WT</given-names>
              </name>
            </person-group>
            <article-title>A Randomized Trial of Intensive versus Standard Blood-Pressure Control.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Nov</month>
            <day>26</day>
            <volume>373</volume>
            <issue>22</issue>
            <fpage>2103</fpage>
            <page-range>2103-16</page-range>
            <pub-id pub-id-type="pmid">26551272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimm</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mok</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Back</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Jee</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>The J-curve between Diastolic Blood Pressure and Risk of All-cause and Cardiovascular Death.</article-title>
            <source>Korean Circ J</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-47</page-range>
            <pub-id pub-id-type="pmid">29322696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>The J-Curve Phenomenon in Hypertension.</article-title>
            <source>Pulse (Basel)</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-60</page-range>
            <pub-id pub-id-type="pmid">27493904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zweifler</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Shahab</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Pseudohypertension: a new assessment.</article-title>
            <source>J Hypertens</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">8382233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benetos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petrovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strandberg</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hypertension Management in Older and Frail Older Patients.</article-title>
            <source>Circ Res</source>
            <year>2019</year>
            <month>Mar</month>
            <day>29</day>
            <volume>124</volume>
            <issue>7</issue>
            <fpage>1045</fpage>
            <page-range>1045-1060</page-range>
            <pub-id pub-id-type="pmid">30920928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ojji</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Mayosi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Badri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cornelius</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Smythe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barasa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Damasceno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dzudie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mondo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ogah</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ogola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sani</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Shedul</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Shedul</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rayner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Okpechi</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Sliwa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Poulter</surname>
                <given-names>N</given-names>
              </name>
              <collab>CREOLE Study Investigators</collab>
            </person-group>
            <article-title>Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.</article-title>
            <source>N Engl J Med</source>
            <year>2019</year>
            <month>Jun</month>
            <day>20</day>
            <volume>380</volume>
            <issue>25</issue>
            <fpage>2429</fpage>
            <page-range>2429-2439</page-range>
            <pub-id pub-id-type="pmid">30883050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29843.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poblete</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Barticevic</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bast&#x000ed;as</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Quevedo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>[Effectiveness of a case management intervention for high blood pressure and type II diabetes in primary health care].</article-title>
            <source>Rev Med Chil</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>146</volume>
            <issue>11</issue>
            <fpage>1269</fpage>
            <page-range>1269-1277</page-range>
            <pub-id pub-id-type="pmid">30725040</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
